RDGL

Vivos (QB) Stock Price

0.03828
0.000655 (1.74%)
0.03828
Best deals to access real time data!
Small Cap Basic
Monthly Subscription
for only
$33.03
Ultimate Trader (Monthly)
Monthly Subscription
for only
$80.29
DDE w/Realtime (Monthly)
Monthly Subscription
for only
$34.10
VAT not included
Company Name Stock Ticker Symbol Market Type
Vivos Inc (QB) RDGL OTCMarkets Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
0.000655 1.74% 0.03828 0.035 0.0387 0.036 0.037625 16:00:05
Bid Price Ask Price Spread Spread % News
0.036 0.0387 0.0027 6.98% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
25 133,528 $ 0.036714 $ 4,902 349,015 0.0065 - 0.075
Last Trade Time Type Quantity Stock Price Currency
15:50:33 7,666 $ 0.03828 USD

Vivos (QB) Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 7.91M 216.06M 143.65M $ - $ - - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
13.29k $ - 0.00% - -

more financials information »

Vivos (QB) News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical RDGL Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.0380.04950.0350.04211591,035,7030.000280.74%
1 Month0.0260.04950.01990.036981719,0710.0122847.23%
3 Months0.024550.04950.01350.0331831370,7540.0137355.93%
6 Months0.0370.04950.01350.0318017352,1690.001283.46%
1 Year0.0690.0750.00650.0378232409,899-0.03072-44.52%
3 Years0.0850.1080.00240.01169136,061,110-0.04672-54.96%
5 Years0.00091.000.00020.00802736,906,8110.037384,153.33%

Vivos (QB) Description

Vivos Inc, a medical device company in the process of researching and developing minimally invasive treatments to combat cancer in humans and animals, is pleased to report several significant outcomes after its signature product, IsoPet, was used to treat a hind-leg soft-tissue sarcoma in a Sheltie at the University of Missouri Veterinary Health Center in Columbia, Missouri.


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.